The Science 37 Metasite in Action: Accelerating Enrollment for an Infectious Disease Trial.
A biopharma company was conducting a phase II randomized controlled trial for an infectious disease. The protocol required the participation of high-risk comorbidity patients ages 65+ or 18+ that tested positive with symptom onset within a short timeframe. Learn how Science 37 delivered:
- A 3 year reduction of timeline
- >86% enrollment
- 94% retention rate